FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080427990> ?p ?o ?g. }

• W3080427990 endingPage "5513" @default.
• W3080427990 startingPage "5513" @default.
• W3080427990 abstract "5513 Background: The role and the duration of NACT in ovarian cancer are debated. A randomized trial comparing upfront surgery versus 3 courses of NACT (Vergote 2008) demonstrated similar survival, but less morbidity in favor of NACT. However, pathological complete remissions (pCR) were rare and 68% of pts still had lesions greater than 2 cm after 3 courses of NACT. The rate of pCR correlates with a better survival in other tumors, such as breast cancer, and its rate is higher after 6–8 courses of NACT. We conducted this study to verify the incidence of optimal pathological remission after 6 courses of NACT. Methods: Eligible pts had stage IIIC-IV EOC unsuitable for optimal upfront surgery and were treated with 6 cycles of carboplatin AUC 5 and paclitaxel 175 mg/sm, every 3 weeks before surgery. We considered as optimal pathological responders: 1) the pts with absence of cancer cells in surgical specimens, and 2) the pts with no macroscopic residual after surgery and with only small clusters or individual cancer cells in surgical specimens. All the other cases were considered as pathological nonresponders, even if a relevant shrinkage of tumor burden and an optimal surgical debulking were obtained. Results: 35 stage IIIC/IV pts were enrolled; 33 (94%) completed 6 courses of NACT. We observed 18 (51%) pathological responders, and 17 pathological nonresponders (as defined above). Overall, in 20 (57%) pts the goal of no residual tumor after surgery was achieved. After a median follow-up of 21 mo.s, 21 pts progressed (median PFS 15 mo.s) and 10 pts died. As expected, pts with tumor residual after surgery less than 1 cm survived significantly longer than patients with a greater residual (p .0005). The median overall survival was longer in pathological responders (median not reached) vs nonresponders (19.8 mo.s) (p.03). Conclusions: In our study an optimal pathological response occurred in 51% of cases after 6 cycles of carboplatin-paclitaxel, doubling the results described in the literature with 3 courses of NACT. Given that an optimal pathological response correlates with a longer survival compared to a sub-optimal one, a randomized study of 6 vs 3 courses of NACT in order to verify if the increase in pathological response rate will translate into a survival benefit is warranted. No significant financial relationships to disclose." @default.
• W3080427990 created "2020-09-01" @default.
• W3080427990 creator A5018118709 @default.
• W3080427990 creator A5035598846 @default.
• W3080427990 creator A5054546157 @default.
• W3080427990 creator A5062685578 @default.
• W3080427990 creator A5070644908 @default.
• W3080427990 creator A5086086408 @default.
• W3080427990 creator A5041627106 @default.
• W3080427990 date "2009-05-20" @default.
• W3080427990 modified "2023-10-18" @default.
• W3080427990 title "Effect of six courses of neoadjuvant chemotherapy on pathological complete remission in advanced ovarian cancer" @default.
• W3080427990 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.5513" @default.
• W3080427990 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27962463" @default.
• W3080427990 hasPublicationYear "2009" @default.
• W3080427990 type Work @default.
• W3080427990 sameAs 3080427990 @default.
• W3080427990 citedByCount "1" @default.
• W3080427990 crossrefType "journal-article" @default.
• W3080427990 hasAuthorship W3080427990A5018118709 @default.
• W3080427990 hasAuthorship W3080427990A5035598846 @default.
• W3080427990 hasAuthorship W3080427990A5041627106 @default.
• W3080427990 hasAuthorship W3080427990A5054546157 @default.
• W3080427990 hasAuthorship W3080427990A5062685578 @default.
• W3080427990 hasAuthorship W3080427990A5070644908 @default.
• W3080427990 hasAuthorship W3080427990A5086086408 @default.
• W3080427990 hasConcept C121608353 @default.
• W3080427990 hasConcept C126322002 @default.
• W3080427990 hasConcept C141071460 @default.
• W3080427990 hasConcept C143998085 @default.
• W3080427990 hasConcept C146357865 @default.
• W3080427990 hasConcept C151730666 @default.
• W3080427990 hasConcept C207886595 @default.
• W3080427990 hasConcept C2776694085 @default.
• W3080427990 hasConcept C2778239845 @default.
• W3080427990 hasConcept C2780427987 @default.
• W3080427990 hasConcept C2781100745 @default.
• W3080427990 hasConcept C2781451048 @default.
• W3080427990 hasConcept C530470458 @default.
• W3080427990 hasConcept C71924100 @default.
• W3080427990 hasConcept C86803240 @default.
• W3080427990 hasConceptScore W3080427990C121608353 @default.
• W3080427990 hasConceptScore W3080427990C126322002 @default.
• W3080427990 hasConceptScore W3080427990C141071460 @default.
• W3080427990 hasConceptScore W3080427990C143998085 @default.
• W3080427990 hasConceptScore W3080427990C146357865 @default.
• W3080427990 hasConceptScore W3080427990C151730666 @default.
• W3080427990 hasConceptScore W3080427990C207886595 @default.
• W3080427990 hasConceptScore W3080427990C2776694085 @default.
• W3080427990 hasConceptScore W3080427990C2778239845 @default.
• W3080427990 hasConceptScore W3080427990C2780427987 @default.
• W3080427990 hasConceptScore W3080427990C2781100745 @default.
• W3080427990 hasConceptScore W3080427990C2781451048 @default.
• W3080427990 hasConceptScore W3080427990C530470458 @default.
• W3080427990 hasConceptScore W3080427990C71924100 @default.
• W3080427990 hasConceptScore W3080427990C86803240 @default.
• W3080427990 hasIssue "15_suppl" @default.
• W3080427990 hasLocation W30804279901 @default.
• W3080427990 hasOpenAccess W3080427990 @default.
• W3080427990 hasPrimaryLocation W30804279901 @default.
• W3080427990 hasRelatedWork W1967715255 @default.
• W3080427990 hasRelatedWork W2014215628 @default.
• W3080427990 hasRelatedWork W2020778541 @default.
• W3080427990 hasRelatedWork W2060767396 @default.
• W3080427990 hasRelatedWork W2072767112 @default.
• W3080427990 hasRelatedWork W2105623825 @default.
• W3080427990 hasRelatedWork W2410995755 @default.
• W3080427990 hasRelatedWork W2953658820 @default.
• W3080427990 hasRelatedWork W2968124559 @default.
• W3080427990 hasRelatedWork W59268075 @default.
• W3080427990 hasVolume "27" @default.
• W3080427990 isParatext "false" @default.
• W3080427990 isRetracted "false" @default.
• W3080427990 magId "3080427990" @default.
• W3080427990 workType "article" @default.